QuadMedicine, Inc. (464490.KQ)
KOSDAQ · KRW · Healthcare · Medical Instruments & Supplies
₩4,090 (-2.39%) as of
Key statistics
- Market cap
- 46.39B
- Dividend yield
- 0.00%
- 52-week range
- 0.00 – 27,150.00
- Revenue (TTM)
- 7.14B
- Profit margin
- -141.51%
About QuadMedicine, Inc.
QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporated in 2016 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Seongnam-si, South Korea
- Employees
- 104
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.